Literature DB >> 3368469

Evidence for a role of delta sleep-inducing peptide in slow-wave sleep and sleep-related growth hormone release in the rat.

K S Iyer1, G A Marks, A J Kastin, S M McCann.   

Abstract

To examine the role of delta sleep-inducing peptide (DSIP) in sleep-related growth hormone (GH) release, male rats were deprived of sleep for 4 hr by placing them on a slowly rotating wheel. Sleep deprivation by this method caused a significant increase in GH release, as indicated by the increase in plasma GH concentrations (P less than 0.01), and also in the amount of slow-wave sleep (SWS) (P less than 0.001) above initial values after removal of the animals from the rotating wheel. These increases were blocked by microinjection into the third cerebral ventricle of highly specific antiserum to DSIP. In control rats receiving an equal volume of normal rabbit serum, the significant increase in plasma GH as well as SWS remained after removal of the rats from the wheel. The increased release of endogenous DSIP in the sleep-deprived animals may have caused an increase in SWS as well as plasma GH. Since DSIP increases plasma GH after its injection into the third cerebral ventricle and since passive immunization against DSIP blocks the increase in SWS and GH release that follows the 4 hr of sleep deprivation, the results suggest that DSIP can be a physiological stimulus for sleep-related GH release as well as for the induction of SWS.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3368469      PMCID: PMC280272          DOI: 10.1073/pnas.85.10.3653

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  Water, sodium chloride, and food intake induced by injections of cholinergic and adrenergic drugs into the third ventricle of the rat brain.

Authors:  J Antunes-Rodrigues; S M McCann
Journal:  Proc Soc Exp Biol Med       Date:  1970-04

2.  The delta-sleep inducing peptide (DSIP) increases duration of sleep in rats.

Authors:  S Kafi; M Monnier; J M Gallard
Journal:  Neurosci Lett       Date:  1979-07       Impact factor: 3.046

3.  Effects of repeated DSIP and DSIP-P administration on the circadian locomotor activity of rats.

Authors:  M Graf; H Christen; H J Tobler; P F Maier; G A Schoenenberger
Journal:  Pharmacol Biochem Behav       Date:  1981-11       Impact factor: 3.533

4.  The influence of synthetic DSIP (delta-sleep-inducing-peptide) on disturbed human sleep.

Authors:  D Schneider-Helmert; G A Schoenenberger
Journal:  Experientia       Date:  1981

5.  Sleep-promoting effect of the sleep-promoting substance (SPS) and delta sleep-inducing peptide (DSIP) in the mouse.

Authors:  H Nagasaki; K Kitahama; J L Valatx; M Jouvet
Journal:  Brain Res       Date:  1980-06-16       Impact factor: 3.252

6.  Radioimmunoassay of DSIP-like material in rat brain.

Authors:  A J Kastin; C Nissen; A V Schally; D H Coy
Journal:  Brain Res Bull       Date:  1978 Nov-Dec       Impact factor: 4.077

7.  Analysis of sleep-wakefulness rhythms in male rats after suprachiasmatic nucleus lesions and ocular enucleation.

Authors:  N Ibuka; S I Inouye; H Kawamura
Journal:  Brain Res       Date:  1977-02-11       Impact factor: 3.252

8.  Additional evidence that small amounts of a peptide can cross the blood-brain barrier.

Authors:  A J Kastin; C Nissen; A V Schally; D H Coy
Journal:  Pharmacol Biochem Behav       Date:  1979-12       Impact factor: 3.533

9.  Pulsatile growth hormone release in the rat: failure to demonstrate a correlation with sleep phases.

Authors:  J O Willoughby; J B Martin; L P Renaud; P Brazeau
Journal:  Endocrinology       Date:  1976-04       Impact factor: 4.736

10.  Characterization of a delta-electroencephalogram (-sleep)-inducing peptide.

Authors:  G A Schoenenberger; M Monnier
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.